Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

Functional investigations of B-cell lymphoma mutations disrupting membrane phospholipid transport

EF 2024-25

Résumé
Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of blood cancer in adults. While DLBCL tumours behave differently across patients, almost everyone receives the same drugs, meaning that treatment fails in ~40% of cases. Thus, to develop novel treatment approaches, we must study how these tumours develop, and what fuels their growth. Scientists have placed DLBCL tumours into categories, based on their genetic characteristics. Tumours in one category, called BN2, are very aggressive and fatal. Unfortunately, how BN2 tumours form and thrive is not well known. What we know is that BN2 tumours often carry a mutation that alters the organization of the outer lining (membrane) of B cells, an immune cell that gives rise to DLBCL. By understanding how these changes in the B cell membrane affect their function, we can lay the groundwork into understanding how BN2 tumours develop and grow. We propose that changes in the B cell membrane affect their behaviour, and that of neighboring cells, promoting the development of aggressive tumours. First, we will study how changes in the cell membrane affect normal B cell function. In mice, we introduced the same mutation found in BN2 DLBCL tumours into B cells, and will explore how the mutant B cells respond to different cues. We also aim to study whether changes in the B cell membrane are responsible for the aggressiveness of BN2 tumours. To do so, we will modify our mice to develop tumours, to study when tumours develop and how cancerous B cells behave. Our study will be the first to explore how BN2 tumours originate, and cause aggressive disease. By understanding how traits found in DLBCL affects normal B cell function, our work can identify potential weaknesses to be exploited to overcome current treatment challenges.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529673
Name
Zhao Jenny
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Functional investigations of B-cell lymphoma mutations disrupting membrane phospholipid transport
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
B Cells; Clonal Precursors Populations; Diffuse Large B-Cell Lymphoma; Flippases; Follicular B Cells; Immune Microenvironment; Marginal Zone B Cells; Multiparametric Flow Cytometry; Plasma Membrane Asymmetry; Preclinical Mouse Models
Abstract
Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of blood cancer in adults. While DLBCL tumours behave differently across patients, almost everyone receives the same drugs, meaning that treatment fails in ~40% of cases. Thus, to develop novel treatment approaches, we must study how these tumours develop, and what fuels their growth. Scientists have placed DLBCL tumours into categories, based on their genetic characteristics. Tumours in one category, called BN2, are very aggressive and fatal. Unfortunately, how BN2 tumours form and thrive is not well known. What we know is that BN2 tumours often carry a mutation that alters the organization of the outer lining (membrane) of B cells, an immune cell that gives rise to DLBCL. By understanding how these changes in the B cell membrane affect their function, we can lay the groundwork into understanding how BN2 tumours develop and grow. We propose that changes in the B cell membrane affect their behaviour, and that of neighboring cells, promoting the development of aggressive tumours. First, we will study how changes in the cell membrane affect normal B cell function. In mice, we introduced the same mutation found in BN2 DLBCL tumours into B cells, and will explore how the mutant B cells respond to different cues. We also aim to study whether changes in the B cell membrane are responsible for the aggressiveness of BN2 tumours. To do so, we will modify our mice to develop tumours, to study when tumours develop and how cancerous B cells behave. Our study will be the first to explore how BN2 tumours originate, and cause aggressive disease. By understanding how traits found in DLBCL affects normal B cell function, our work can identify potential weaknesses to be exploited to overcome current treatment challenges.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhao, Jenny
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~